Cytolytic T‐cell responses of cancer patients vaccinated with a MAGE antigen
- 1 October 2002
- journal article
- case report
- Published by Wiley in Immunological Reviews
- Vol. 188 (1) , 33-42
- https://doi.org/10.1034/j.1600-065x.2002.18804.x
Abstract
Summary: ‘Cancer‐germline’ genes such as the MAGE gene family are expressed in many tumors and in male germline cells but not in normal tissues. They encode shared tumor‐specific antigens, which have...Keywords
This publication has 38 references indexed in Scilit:
- Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?Published by Elsevier ,2003
- Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patientsInternational Journal of Cancer, 2001
- Degenerate Immunogenicity of an HLA-A2-Restricted Hepatitis B Virus Nucleocapsid Cytotoxic T-Lymphocyte Epitope That Is Also Presented by HLA-B51Journal of Virology, 2001
- A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 moleculesTissue Antigens, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancerInternational Journal of Cancer, 1998
- Isolation and Characterization of PAGE-1 andGAGE-7Journal of Biological Chemistry, 1998
- The expression of mouse geneP1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigenInternational Journal of Cancer, 1997
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991